191 related articles for article (PubMed ID: 21426283)
1. Urban-rural differences in prostate cancer outcomes in Australia: what has changed?
Baade PD; Youlden DR; Coory MD; Gardiner RA; Chambers SK
Med J Aust; 2011 Mar; 194(6):293-6. PubMed ID: 21426283
[TBL] [Abstract][Full Text] [Related]
2. Urban-rural differences in prostate cancer mortality, radical prostatectomy and prostate-specific antigen testing in Australia.
Coory MD; Baade PD
Med J Aust; 2005 Feb; 182(3):112-5. PubMed ID: 15698354
[TBL] [Abstract][Full Text] [Related]
3. Rural-Urban Differences in Prostate-Specific Antigen (PSA) Screening and Its Outcomes in New Zealand.
Obertová Z; Hodgson F; Scott-Jones J; Brown C; Lawrenson R
J Rural Health; 2016; 32(1):56-62. PubMed ID: 26174590
[TBL] [Abstract][Full Text] [Related]
4. Geographic variation in prostate cancer survival in New South Wales.
Yu XQ; Luo Q; Smith DP; O'Connell DL; Baade PD
Med J Aust; 2014 Jun; 200(10):586-90. PubMed ID: 24882490
[TBL] [Abstract][Full Text] [Related]
5. Treatment of early-stage prostate cancer among rural and urban patients.
Baldwin LM; Andrilla CH; Porter MP; Rosenblatt RA; Patel S; Doescher MP
Cancer; 2013 Aug; 119(16):3067-75. PubMed ID: 23765584
[TBL] [Abstract][Full Text] [Related]
6. The impact of the United States Preventive Services Task Force (USPTSTF) recommendations against prostate-specific antigen (PSA) testing on PSA testing in Australia.
Zargar H; van den Bergh R; Moon D; Lawrentschuk N; Costello A; Murphy D
BJU Int; 2017 Jan; 119(1):110-115. PubMed ID: 27454454
[TBL] [Abstract][Full Text] [Related]
7. Geographic variation in compliance with Australian colorectal cancer screening programs: the role of attitudinal and cognitive traits.
Goodwin BC; March S; Ireland M; Crawford Williams F; Manksi D; Ford M; Dunn J
Rural Remote Health; 2019 Jul; 19(3):4957. PubMed ID: 31340653
[TBL] [Abstract][Full Text] [Related]
8. Long-term radical prostatectomy outcomes among participants from the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam.
Loeb S; Zhu X; Schroder FH; Roobol MJ
BJU Int; 2012 Dec; 110(11):1678-83. PubMed ID: 22998182
[TBL] [Abstract][Full Text] [Related]
9. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
10. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A
BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Outcomes after Deferred Radical Prostatectomy in Men Initially Treated with Active Surveillance.
Godtman RA; Schafferer M; Pihl CG; Stranne J; Hugosson J
J Urol; 2018 Oct; 200(4):779-785. PubMed ID: 29730198
[TBL] [Abstract][Full Text] [Related]
12. Rural-Urban Disparities in Time to Diagnosis and Treatment for Colorectal and Breast Cancer.
Bergin RJ; Emery J; Bollard RC; Falborg AZ; Jensen H; Weller D; Menon U; Vedsted P; Thomas RJ; Whitfield K; White V
Cancer Epidemiol Biomarkers Prev; 2018 Sep; 27(9):1036-1046. PubMed ID: 29987098
[No Abstract] [Full Text] [Related]
13. Patterns of prostate-specific antigen testing by remoteness of residence and socio-economic status: An Australian population-based study.
Calopedos RJS; Bang A; Baade P; Yu XQ; Ruthven S; Patel MI; Smith DP
Aust J Rural Health; 2019 Jun; 27(3):216-223. PubMed ID: 31070837
[TBL] [Abstract][Full Text] [Related]
14. Changes in prostate specific antigen (PSA) "screening" patterns by geographic region and socio-economic status in Australia: Analysis of medicare data in 50-69 year old men.
Kohar A; Cramb SM; Pickles K; Smith DP; Baade PD
Cancer Epidemiol; 2023 Apr; 83():102338. PubMed ID: 36841020
[TBL] [Abstract][Full Text] [Related]
15. Rural residency and prostate cancer specific mortality: results from the Victorian Radical Prostatectomy Register.
Papa N; Lawrentschuk N; Muller D; MacInnis R; Ta A; Severi G; Millar J; Syme R; Giles G; Bolton D
Aust N Z J Public Health; 2014 Oct; 38(5):449-54. PubMed ID: 24962513
[TBL] [Abstract][Full Text] [Related]
16. Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003.
Khan MA; Han M; Partin AW; Epstein JI; Walsh PC
Urology; 2003 Jul; 62(1):86-91; discussion 91-2. PubMed ID: 12837428
[TBL] [Abstract][Full Text] [Related]
17. Localised prostate cancer in elderly men aged 80-89 years, findings from a population-based registry.
Vatandoust S; Kichenadasse G; O'Callaghan M; Vincent AD; Kopsaftis T; Walsh S; Borg M; Karapetis CS; Moretti K
BJU Int; 2018 May; 121 Suppl 3():48-54. PubMed ID: 29603585
[TBL] [Abstract][Full Text] [Related]
18. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.
Freedland SJ; Humphreys EB; Mangold LA; Eisenberger M; Dorey FJ; Walsh PC; Partin AW
JAMA; 2005 Jul; 294(4):433-9. PubMed ID: 16046649
[TBL] [Abstract][Full Text] [Related]
19. Do younger men have better biochemical outcomes after radical prostatectomy?
Freedland SJ; Presti JC; Kane CJ; Aronson WJ; Terris MK; Dorey F; Amling CL;
Urology; 2004 Mar; 63(3):518-22. PubMed ID: 15028449
[TBL] [Abstract][Full Text] [Related]
20. Men under the age of 55 years with screen detected prostate cancer do not have less significant disease compared to older men in a population of patients in Australia.
Dantanarayana ND; Hossack T; Cozzi P; Brooks A; Lau H; Delprado W; Patel MI
BMC Urol; 2015 Dec; 15():124. PubMed ID: 26715039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]